
Medifast Inc
NYSE:MED

Medifast Inc
Total Equity
Medifast Inc
Total Equity Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Company | Total Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
---|---|---|---|---|---|---|
![]() |
Medifast Inc
NYSE:MED
|
Total Equity
$210.1m
|
CAGR 3-Years
1%
|
CAGR 5-Years
15%
|
CAGR 10-Years
10%
|
|
![]() |
Estee Lauder Companies Inc
NYSE:EL
|
Total Equity
$4.2B
|
CAGR 3-Years
-12%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
1%
|
|
![]() |
Bellring Brands Inc
NYSE:BRBR
|
Total Equity
-$146.6m
|
CAGR 3-Years
63%
|
CAGR 5-Years
42%
|
CAGR 10-Years
N/A
|
|
![]() |
Coty Inc
NYSE:COTY
|
Total Equity
$3.8B
|
CAGR 3-Years
3%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
19%
|
|
![]() |
Inter Parfums Inc
NASDAQ:IPAR
|
Total Equity
$744.9m
|
CAGR 3-Years
9%
|
CAGR 5-Years
10%
|
CAGR 10-Years
7%
|
|
![]() |
elf Beauty Inc
NYSE:ELF
|
Total Equity
$767.4m
|
CAGR 3-Years
36%
|
CAGR 5-Years
26%
|
CAGR 10-Years
N/A
|
Medifast Inc
Glance View
Medifast, Inc. engages in the provision of healthy living products and programs. The company is headquartered in Owings Mills, Maryland and currently employs 984 full-time employees. The firm's operations are conducted through its subsidiaries Jason Pharmaceuticals, Inc., OPTAVIA, LLC, Jason Enterprises, Inc., Jason Properties, LLC, Medifast Franchise Systems, Inc., Seven Crondall Associates, LLC, Corporate Events, Inc., OPTAVIA (Hong Kong) Limited, OPTAVIA (Singapore) PTE. LTD and OPTAVIA Health Consultation (Shanghai) Co., Ltd. The firm's product line includes approximately 137 consumable options, including, bars, bites, pretzels, puffs, cereal crunch, drinks, hearty choices, oatmeal, pancakes, pudding, soft serve, shakes, smoothies, soft bakes, and soups. The Company, through Medifast Direct, its direct-to-consumer business unit.

See Also
What is Medifast Inc's Total Equity?
Total Equity
210.1m
USD
Based on the financial report for Dec 31, 2024, Medifast Inc's Total Equity amounts to 210.1m USD.
What is Medifast Inc's Total Equity growth rate?
Total Equity CAGR 10Y
10%
Over the last year, the Total Equity growth was 4%. The average annual Total Equity growth rates for Medifast Inc have been 1% over the past three years , 15% over the past five years , and 10% over the past ten years .